Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The COMBINE Study: The CKD Optimal Management With BInders and NicotinamidE

NCT02258074 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT02258074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02258074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The COMBINE Study: The CKD Optimal Management With BInders and NicotinamidE
Lead sponsor
The Cleveland Clinic
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2015
Completion date
September 30, 2019
Enrollment
205 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease